Skip to content

Clinical study on the quantitative analysis of the effect of peripheral defocus on the choroids of myopia children based on SS-OCTA

Clinical study on the quantitative analysis of the effect of peripheral defocus on the choroids of myopia children based on SS-OCTA

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300068928
Enrollment
Unknown
Registered
2023-03-01
Start date
2023-03-01
Completion date
Unknown
Last updated
2023-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

myopia

Interventions

group 1:Common frame glasses
group 2:Peripheral defocus frame glasses

Sponsors

Yongchuan Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
8 Years to 12 Years

Inclusion criteria

Inclusion criteria: 1. Aged 8-12 years, with the written consent of the guardian, no gender limit; 2. The equivalent spherical diopter of objective optometry under mydriasis of both eyes is between -0.75 D (inclusive) and -4.75D (inclusive), the astigmatism is less than or equal to 1.50D, and the anisometropia of both eyes after the equivalent spherical lens is <= 1.00D; 3. The best corrected visual acuity of binocular subjective optometry is greater than or equal to 1.0; 4. Volunteer to participate in this clinical trial and sign the informed consent form; 5. Emmetropia children with diopters -0.50D<SE<+0.50D.

Exclusion criteria

Exclusion criteria: 1. Have a history of ocular trauma or intraocular surgery; 2. Clinically significant slit lamp findings; 3. Abnormal intraocular pressure (intraocular pressure 21 mmHg or bilateral intraocular pressure difference >= 5 mmHg); 4. Patients with other eye diseases, such as uveitis and other inflammation, glaucoma, cataract, fundus disease, eye tumor, eye trauma, and dominant strabismus; And any eye disease affecting visual function; 5. Patients with systemic diseases that cause low immunity (such as acute and chronic sinusitis, diabetes, Down's syndrome, rheumatoid arthritis, psychotic patients or other diseases that researchers think are not suitable for wearing glasses); 6. Those who have participated in drug clinical trials within three months, or/and have used any myopia control products, such as specially designed myopia control lenses such as corneal shaping lenses, multifocal contact lenses, progressive multifocal lenses, atropine drugs, etc; 7. Only one eye meets the inclusion criteria; 8. Those who cannot perform eye examination regularly; 9. Dominant strabismus; 10. Those who cannot be selected as determined by the researcher.

Design outcomes

Primary

MeasureTime frame
axial length;choroidal thickness;diopter;

Secondary

MeasureTime frame
choroidal blood flow;

Countries

China

Contacts

Public ContactLi Hua

Yongchuan Hospital of Chongqing Medical University

15086951976@yeah.net+86 150 8695 1976

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026